Neurotherapeutics
 | |
Abbreviated title (ISO 4) | Neurotherapeutics |
|---|---|
| Discipline | Neurology |
| Language | English |
| Edited by | Maral Mouradian |
| Publication details | |
| Publisher |
Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics |
Publication history | 2004-present |
| Frequency | Quarterly |
| 5.054 | |
| Indexing | |
| ISSN |
1933-7213 (print) 1878-7479 (web) |
| LCCN | 2006215616 |
| OCLC no. | 82448136 |
| Links | |
Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders. It was established in 2004 and is published by Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics. The editor-in-chief is Maral Mouradian (Robert Wood Johnson Medical School). The founding editor-in-chief was Alan I. Faden (University of Maryland School of Medicine).
Abstracting and indexing
The journal is abstracted and indexed in:
- Science Citation Index Expanded
- Index Medicus/PubMed/MEDLINE
- Scopus
- PsycINFO
- EMBASE
- Chemical Abstracts Service
- EBSCO databases
- Academic OneFile
- Current Contents/Life Sciences
- Current Contents/Clinical Medicine
According to the Journal Citation Reports, the journal has a 2014 impact factor of 5.054.[1]
References
- ↑ "Neurotherapeutics". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
External links
This article is issued from Wikipedia - version of the 5/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.